Home › Funds › Casdin Capital › BEAM
Casdin Capital position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.35M sh
Reported value held$46.33M
Portfolio Weight2.32%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 818.82K | $71.25M | New |
| Q4 2021 | 818.82K | $65.25M | Hold |
| Q1 2022 | 818.82K | $46.92M | Hold |
| Q2 2022 | 375.00K | $14.52M | Reduce |
| Q3 2022 | 370.00K | $17.63M | Reduce |
| Q4 2022 | 370.00K | $14.47M | Hold |
| Q1 2023 | 570.00K | $17.45M | Add |
| Q2 2023 | 570.00K | $18.20M | Hold |
| Q3 2023 | 570.00K | $13.71M | Hold |
| Q4 2023 | 528.00K | $14.37M | Reduce |
| Q1 2024 | 675.00K | $22.30M | Add |
| Q2 2024 | 675.00K | $15.82M | Hold |
| Q3 2024 | 775.00K | $18.99M | Add |
| Q4 2024 | 1.25M | $31.00M | Add |
| Q1 2025 | 1.43M | $27.84M | Add |
| Q2 2025 | 1.45M | $24.66M | Add |
| Q3 2025 | 1.60M | $38.83M | Add |
| Q4 2025 | 1.60M | $44.35M | Hold |
| Q1 2026 | 1.35M | $32.17M | Reduce |
| Q2 2026 | 1.35M | $46.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Vanguard Group 9.19M sh · $254.84M · Q4 2025
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Goldman Sachs Group 1.31M sh · $44.96M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026